Estimation of Insulin Resistance in Obese Adults in Baghdad

Bareq E. Taha; Maysaa J. Majeed

doi:10.32007/jfacmedbagdad.2118

المؤلفون

Bareq E. Taha https://orcid.org/0009-0007-6571-584X
Maysaa J. Majeed https://orcid.org/0009-0002-8884-6715

DOI:

https://doi.org/10.32007/jfacmedbagdad.2118

الملخص

Background Insulin works to control blood sugar levels by sending signals to liver, muscle and fat cells to bring in sugar out of the blood. Obesity, hyperinsulinemia, hyperglycemia, and hyperlipidemia are only a few of the interconnected metabolic disorders that are frequently linked to these diseases. A statistical procedure called the Homeometric Assessment Model (HOMA) is used to determine the insulin resistance and pancreatic cell activity. (HOMA - IR). Both are determined using insulin and fasting plasma glucose (FPG), but utilizing different formulas. Although investigations based on a modified version of HOMA using connective peptide concentrate (C-peptide) are shown, they are extremely scarce.

Objective: A study of the effect and help (TyG & HOMA-IR) of knowing insulin resistance and early detection of prediabetes.

Subjects, Material, and Method: Analytical cross-sectional and cohort designs are the two types of statistical designs. The study was conducted on 160 volunteers, recruited at the beginning of the study and chosen from an age group based on the study data and the preliminary analysis, with ages ranging from (40-70 years). They were separated into two groups: the first group includes 80 individuals, after adopting an average body mass index of more than 25, who suffer from insulin resistance, and the second group includes 80 healthy individuals who do not suffer from insulin resistance and whose body mass index is less than 25. It was determined Blood glucose, lipid profile, and HBA1C using Cobas c111 on serum samples from both groups. Fasting insulin was determined using Cobas E411 and serum glycine using ELISA kits.

Results: After conducting the statistical procedures for the results of the subjects for each of TyG, HOMA - IR, it was found that there was a significant change and p- value (0,00).

Conclusion: HOMA-IR has had an important role in the evaluation, detection and prognosis of prediabetes. It also helps detect early complications associated with T2DM and helps determine the best treatment options. It also found that the TyG index beats the HOMA-IR for predicting prediabetes. It has the best potential for early detection and prevention of prediabetes

التنزيلات

تنزيل البيانات ليس متاحًا بعد.

السير الشخصية للمؤلفين

Bareq E. Taha
Maysaa J. Majeed

المراجع

Hamer JA, Testani D, Mansur RB, Lee Y, Subramaniapillai M, McIntyre RS. Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression. Experimental neurology. 2019 May 1; 315:1-8. https://doi.org/10.1016/j.expneurol.2019.01.016.

James DE, Stöckli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nature Reviews Molecular Cell Biology. 2021 Nov; 22(11):751-71. https://doi.org/10.1038/s41580-021-00390-6.

Kadowaki T, Maegawa H, Watada H, Yabe D, Node K, Murohara T, Wada J. Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan. Diabetes, Obesity and Metabolism. 2022 Dec;24(12):2283-96.

Saleh BO, Majeed MJ, Oreaby GM. Irisin impact as a medication that ameliorate and hinder the development of insulin resistance associated disorders without regular exercise (experimental study). IOSR Journal of Dental and Medical Sciences. 2014 Sep; 13(9):28-35. https://doi.org/10.9790/0853-13932835.

Al-Khafajy DA, Majeed MJ, Al-Azzawi OF, Khaleel AI. Role of CoQ10 and IGFBP-1 in Obese Male Patients with Diabetic Mellitus Type II. Indian Journal of Forensic Medicine & Toxicology. 2021; 15(1):2204-9.

ABED E, Manal K Rasheed, Khalaf G. Hussein. Assessment of Total Procollagen Type 1 Intact N-terminal Propeptide, C-telopeptide of type 1 collagen, Bone Mineral Density and its Relationship to Body Mass Index in Men with Type 2 Diabetes. JFacMedBagdad [Internet]. 2022 Jul. 24 [cited 2023 Apr. 25]; 64(2):81-5.

https://doi.org/10.32007/jfacmedbagdad.6421942.

Jasim OH, Mahmood MM, Ad'hiah AH. Prevalence and Prediction of Prediabetes among Apparently Healthy Iraqis from Baghdad. Health Education and Health Promotion. 2022 May 10; 10(2):411-21.

Yaribeygi H, Farrokhi FR, Butler AE, Sahebkar A. Insulin resistance: Review of the underlying molecular mechanisms. Journal of cellular physiology. 2019 Jun; 234(6):8152-61. https://doi.org/10.1002/jcp.27603.

MJ A. ++ Diagnostic Usefulness of HOMA-β and HOMA-IR in Diabetes Mellitus-A Review. International Journal of Pharmaceutical Research & Allied Sciences. 2019 Jan 1; 8(1).

Liu XC, He GD, Lo K, Huang YQ, Feng YQ. The triglyceride-glucose index, an insulin resistance marker, was non-linear associated with all-cause and cardiovascular mortality in the general population. Frontiers in cardiovascular medicine. 2021 Jan 14;7:628109. https://doi.org/10.3389/fcvm.2020.628109.

Park HM, Lee HS, Lee YJ, Lee JH. The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance. Diabetes Research and Clinical Practice. 2021 Oct 1; 180: 109042. https://doi.org/10.1016/j.diabres.2021.109042.

VK RN, Satheesh P, Shenoy MT, Kalra S. Triglyceride Glucose (TyG) Index: A surrogate biomarker of insulin resistance. JPMA. The Journal of the Pakistan Medical Association. 2022 May 1; 72(5):986-8. https://doi.org/10.47391/JPMA.22-63.

Javed, K. and Fairweather, S.J. Amino acid transporters in the regulation of insulin secretion and signalling. Biochemical Society Transactions. 2019 47(2), pp.571-590. https://doi.org/10.1042/BST20180250.

Abdulrahman Z, Alatrakji MQ, Al-Maliky AA, Hussein KI, Hussain SA. Influence of Metformin Dose and Treatment Adherence on Glycemic Control, Adiposity, and Cardiovascular Risk Markers in Iraqi Patients with T2DM. JFacMedBagdad [Internet]. 2023 Jan. 13 [cited 2023 Apr. 25];64(4):218-26. https://doi.org/10.32007/jfacmedbagdad.6441939.

Dagogo-Jack S. Prediabetes: A Fundamental Text: Pathophysiology, Complications, Management & Reversal. American Diabetes Association; 2022 Oct 26. https://doi.org/10.2337/9781580407625.

Hameed E, Al-Ameri L, Hasan H, Abdulqahar Z. The Cut-off Values of Triglycerides -Glucose Index for Metabolic Syndrome Associated with Type 2 Diabetes Mellitus. Baghdad Science Journal. 2021;19(2):340-346. https://doi.org/10.21123/bsj.2022.19.2.0340.

Eshraq M. Salman, Bushra F. Hasan. The effect of obesity and Insulin Resistance on Liver Enzymes in Type2 Diabetes Mellitus. Baghdad Science Journal.2014;12(3)2015. https://doi.org/10.21123/bsj.12.3.536-545.

Chopra AK. Metabolic syndrome or insulin resistance: Evolution, controversies and association with cardiovascular disease risk. Indian Journal of Clinical Cardiology. 2020 Jun;1(2):77-85. https://doi.org/10.1177/2632463620935030

Ramírez-Manent JI, Jover AM, Martinez CS, Tomás-Gil P, Martí-Lliteras P, López-González ÁA. Waist Circumference Is an Essential Factor in Predicting Insulin Resistance and Early Detection of Metabolic Syndrome in Adults. Nutrients. 2023 Jan 4;15(2):257. https://doi.org/10.3390/nu15020257.

Wondmkun YT. Obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications. Diabetes, metabolic syndrome and obesity: targets and therapy. 2020; 13: 3611. https://doi.org/10.2147/DMSO.S275898.

Chao YP, Kao TW, Chang YW, Peng TC, Chen WL, Wu LW. Utilization of anthropometric parameters as a novel tool for detection of insulin resistance. Clinical Nutrition. 2020 Aug 1;39(8):2571-9. https://doi.org/10.1016/j.clnu.2019.11.023.

Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, Beguinot F, Miele C. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. International journal of molecular sciences. 2019 May13; 20(9):2358.https://doi.org/10.3390/ijms20092358.

Ludwig DS, Aronne LJ, Astrup A, de Cabo R, Cantley LC, Friedman MI, Heymsfield SB, Johnson JD, King JC, Krauss RM, Lieberman DE. The carbohydrate-insulin model: a physiological perspective on the obesity pandemic. The American journal of clinical nutrition. 2021 Dec; 114(6):1873-85. https://doi.org/10.1093/ajcn/nqab270.

Barazzoni R, Gortan Cappellari G, Ragni M, Nisoli E. Insulin resistance in obesity: an overview of fundamental alterations. Eating and Weight disorders-studies on Anorexia, Bulimia and Obesity. 2018 Apr;23:149-57. https://doi.org/10.1007/s40519-018-0481-6.

Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduction and Targeted Therapy. 2022 Jul 6;7(1):216.

https://doi.org/10.1038/s41392-022-01073-0.

Yang J, Lu Y, Bai Y, Cheng Z. Sex‐specific and dose‐response relationships of urinary cobalt and molybdenum levels with glucose levels and insulin resistance in US adults. Journal of Environmental Sciences. 2023 Feb 1;124:42-9. https://doi.org/10.1016/j.jes.2021.10.023.

Selvi NM, Nandhini S, Sakthivadivel V, Lokesh S, Srinivasan AR, Sumathi S. Association of Triglyceride-Glucose Index (TyG index) with HbA1c and Insulin Resistance in Type 2 Diabetes Mellitus. Maedica. 2021 Sep;16(3):375. https://doi.org/10.26574/maedica.2021.16.3.375.